VS
stockvs
Go to ScreenerHub
0QQ6.L

0QQ6.L vs NVO

NVO

In the past 12 months, 0QQ6.L returned +1% while NVO lost 52%.

0QQ6.L
0QQ6.L

Roche Holding AG

$418.64
-10.9%(1M)
Market Cap356.9B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio45.65
ROE41.2%
P/B Ratio9.11
Dividend Yield3.0%
NVO
NVO

Novo Nordisk A/S

$38.58
-21.9%(1M)
Market Cap171.5B
Healthcare
Drug Manufacturers - General
DK
P/E Ratio10.78
ROE61.1%
P/B Ratio5.69
Dividend Yield4.7%
Performance Comparison

Historical returns across multiple timeframes

0QQ6.L leads 6/8
0QQ6.L

0QQ6.L

Roche Holding AG

+1.3%

1Y Return

NVO

NVO

Novo Nordisk A/S

-51.9%

1Y Return

0QQ6.L
0QQ6.L
NVO
NVO

Short Term

1M-6M

0QQ6.L
+3.9%

Medium Term

YTD-1Y

0QQ6.L
+0.5%

Long Term

3Y-10Y

0QQ6.L
+18.5%

Valuation

Compare price multiples and valuation ratios

0QQ6.L: 0NVO: 5
Metric0QQ6.LNVOWinner
P/E Ratio

Price to earnings ratio

45.6510.78NVO
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.573.57NVO
P/B Ratio

Price to book ratio

9.115.69NVO
P/FCF Ratio

Price to free cash flow ratio

20.5919.66NVO
EV/EBITDA

Enterprise value to EBITDA

12.747.56NVO
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

0QQ6.L: 0NVO: 6
Metric0QQ6.LNVOWinner
Gross Margin

Gross profit margin

73.5%81.0%NVO
Operating Margin

Operating profit margin

28.4%41.3%NVO
Net Margin

Net profit margin

12.3%33.1%NVO
ROE

Return on equity

41.2%61.1%NVO
ROA

Return on assets

12.8%18.9%NVO
ROIC

Return on invested capital

18.8%29.5%NVO

Growth

Compare revenue and earnings growth rates

0QQ6.L: 1NVO: 5
Metric0QQ6.LNVOWinner
Revenue Growth (YoY)

Year-over-year revenue growth

-1.4%2.3%NVO
Revenue Growth (3Y)

3-year revenue CAGR

-0.9%18.9%NVO
Revenue Growth (5Y)

5-year revenue CAGR

1.1%18.5%NVO
EPS Growth (YoY)

Year-over-year EPS growth

55.9%1.8%0QQ6.L
EPS Growth (3Y)

3-year EPS CAGR

1.1%23.5%NVO
EPS Growth (5Y)

5-year EPS CAGR

-0.6%20.7%NVO

Balance Sheet & Risk

Compare financial stability and debt levels

0QQ6.L: 3NVO: 2
Metric0QQ6.LNVOWinner
Debt/Equity

Debt to equity ratio

1.210.67NVO
Current Ratio

Current assets to current liabilities

1.290.800QQ6.L
Quick Ratio

Quick assets to current liabilities

1.020.570QQ6.L
Interest Coverage

EBIT to interest expense

10.7318.83NVO
Beta

Stock volatility vs market

0.210.270QQ6.L
Summary
NVO wins 3-1

Valuation

NVO

Profitability

NVO

Growth

NVO

Balance Sheet

0QQ6.L

NVO is more attractively valued. NVO shows stronger profitability. NVO demonstrates better growth. 0QQ6.L has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into 0QQ6.L and NVO with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/0QQ6.L/vs/NVO" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare 0QQ6.L vs NVO on stockvs.app
</a>